Table 6.
Antimicrobial resistance pattern of gram negative bacteria isolated from fistula patient at Hamlin Fistula Hospital, Addis Ababa, Ethiopia
| Bacterial isolates | Antimicrobial Tested | ||||||
|---|---|---|---|---|---|---|---|
| AMC | CIP | CN | F | C | CRO | ||
|
E. coli
(n = 65) |
S | 51(78.4) | 28(43.1) | 25(48.5) | 36(55.4) | 41(63.1) | 45(69.2) |
| I | 0(0.0) | 0(0.0) | 5(7.7) | 3(4.6) | 3(4.6) | 4(6.1) | |
| R | 14(21.6) | 37(56.9) | 35(53.8) | 26(40) | 21(32.2) | 16(24.6) | |
|
Klebsiella spp.
(n = 14) |
S | 14(100) | 3(21.4) | 6(42.8) | 12(85.7) | 10(71.4) | 11(78.6) |
| I | 0(0.0) | 0(0.0) | 1(7.1) | 1(7.5) | 0(0.0) | 1(7.5) | |
| R | 0(0.0) | 11(78.6) | 7(50) | 1(7.5) | 4(28.6) | 2(14.3) | |
|
Pseudomonas spp.
(n = 4) |
S | 1(20) | 3(80) | 4(100) | 1(20) | 3(80) | 4(100) |
| I | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
| R | 3(80) | 1(20) | 0(0.0) | 3(80) | 1(20) | 0(0.0) | |
|
Proteus spp.
(n = 31) |
S | 25(80.6) | 13(41.9) | 12(48.7) | 20(64.5) | 17(54.8) | 21(67.7) |
| I | 0(0.0) | 4(12.9) | 0(0.0) | 2(6.5) | 1(3.2) | 4(12.9) | |
| R | 6(19.4) | 14(45.9) | 19(61.3) | 9(29) | 13(41.9) | 6(19.4) | |
|
Serratia spp.
(n = 3) |
S | 1(33.3) | 0(0.0) | 1(33.3) | 3(100) | 3(100) | 2(66.6) |
| I | 0(0.0) | 1(33.3) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
| R | 2(66.6) | 2(66.6) | 2(66.6) | 0(0.0) | 0(0.0) | 1(33.3) | |
| Total (n = 117) |
S | 92(78.6) | 47(40.2) | 48(41) | 72(61.5) | 74(63.2) | 83(70.9) |
| I | 0(0.0) | 5(4.3) | 6(5.1) | 6(5.1) | 4(3.4) | 9(7.7) | |
| R | 25(21.4) | 65(55.5) | 63(53.8) | 39(33.3) | 39(33.3) | 25(21.4) | |
CRO Ceftriaxone, C Chloramphenicol, CN Gentamicin, F Nitrofurantoin, CIP Ciprofloxacin, AMC Amoxicillin- clavulanic acid